AQR Capital Management

AQR Capital Management’s Cullinan Oncology CGEM Stock Holding History

AQR Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.13M	Buy	360,874 +79,391	+28%	+$1.02M	﹤0.01%	1729
2025 Q4	$2.91M	Buy	281,483 +83,563	+42%	+$754K	﹤0.01%	1895
2025 Q3	$1.17M	Buy	197,920 +177,000	+846%	+$1.3M	﹤0.01%	2329
2025 Q2	$158K	Buy	+20,920	New	+$168K	﹤0.01%	3103
2023 Q4	–	Sell	-21,774	Closed	-$197K	–	2344
2023 Q3	$197K	Sell	21,774 -50,048	-70%	-$521K	﹤0.01%	2146
2023 Q2	$773K	Sell	71,822 -16,470	-19%	-$175K	﹤0.01%	1657
2023 Q1	$903K	Sell	88,292 -23,068	-21%	-$254K	﹤0.01%	1585
2022 Q4	$1.17M	Buy	111,360 +2,958	+3%	+$35.9K	﹤0.01%	1500
2022 Q3	$1.39M	Buy	108,402 +87,493	+418%	+$1.18M	﹤0.01%	1366
2022 Q2	$268K	Buy	+20,909	New	+$237K	﹤0.01%	1900

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return